BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Koulakian H, Allaham W, Vilgrain V, Ronot M. Non-measurable infiltrative HCC: is post-contrast attenuation on CT a sign of tumor response? Eur Radiol 2019;29:4389-99. [PMID: 30413965 DOI: 10.1007/s00330-018-5805-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Awiwi MO, Elsayes KM, Mohamed YI, Altameemi L, Gjoni M, Irshad OM, Sayed Ahmed A, Kaseb AO, Salem U. . JHC 2022;Volume 9:913-27. [DOI: 10.2147/jhc.s379428] [Reference Citation Analysis]
2 Filiberto DM, Toth C, Afzal MO, Byerly S, Lenart EK, Kerwin AJ, Croce MA, Magnotti LJ. Radiographic and Clinical Predictors of Therapeutic Pelvic Angiography. Am Surg 2022;:31348221080429. [PMID: 35404149 DOI: 10.1177/00031348221080429] [Reference Citation Analysis]
3 Kim HI, Lim J, Shim JH. Role of the alpha-fetoprotein response in immune checkpoint inhibitor-based treatment of patients with hepatocellular carcinoma. J Cancer Res Clin Oncol 2021. [PMID: 34459972 DOI: 10.1007/s00432-021-03727-y] [Reference Citation Analysis]
4 Liu C, Smolka S, Papademetris X, Minh DD, Gan G, Deng Y, Lin M, Chapiro J, Wang X, Georgiades C, Hong K. Predicting Infiltrative Hepatocellular Carcinoma Patient Outcome Post-TACE: MR Bias Field Correction Effect on 3D-quantitative Image Analysis. J Clin Transl Hepatol 2020;8:292-8. [PMID: 33083252 DOI: 10.14218/JCTH.2020.00054] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
5 Shuai T, Zhou Y, Shao G, Yang R, Wang L, Wang J, Sun J, Ren L, Wang J, Liao Y, Wei M, Xu Q, Li Y, Zhao L. Bimodal Molecule as NIR-CT Contrast Agent for Hepatoma Specific Imaging. Anal Chem 2020;92:1138-46. [PMID: 31820637 DOI: 10.1021/acs.analchem.9b04212] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]